Prognostic value of liver fibrotic markers in patients with heart failure

25 August 2023 (07:30 - 18:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Atsushi Tada

Mayo Clinic, Rochester (United States of America)

4 More presentations in this session

Presentation thumbnail

Cardiac Troponin T level is not a predictor of mortality in patients with post-cardiotomy shock supported with venoarterial extracorporeal membrane oxygenation.

Doctor M. Celinska-Spodar (Warsaw, PL)

Abstract Slides Video

Presentation thumbnail

The prognostic role of clinical features and biomarkers in patients hospitalized with cardiorenal syndromes

Doctor P. Theofilis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Prognostic significance of growth differentiation factor-15 across the BMI spectrum in patients with chronic heart failure: Insights from the SUPPORT trial

Doctor K. Teramoto (Osaka, JP)

Abstract Slides Video

Presentation thumbnail

Continuous measurement of percutaneous oxygen saturation during 6-minute walk test is useful for stratification of the prognostic risk in patients with heart failure

Doctor I. Sunayama (Nishinomiya, JP)

Abstract Slides Video

Access the full session

Session thumbnail

Emerging evidence for biomarkers in heart failure

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel biomarkers reveal distinct biological phenotypes in heart failure with preserved vs reduced ejection fraction

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources